Advanced Enzyme Technologies Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹308.3
- Today's High:
- ₹329.5
- Open Price:
- ₹325.1
- 52W Low:
- ₹221.1043
- 52W High:
- ₹346.15
- Prev. Close:
- ₹324.65
- Volume:
- 42011
Company Statistics
- Market Cap.:
- ₹37.16 billion
- Book Value:
- 110.448
- Revenue TTM:
- ₹5.67 billion
- Operating Margin TTM:
- 24.48%
- Gross Profit TTM:
- ₹3.61 billion
- Profit Margin:
- 20.57%
- Return on Assets TTM:
- 5.84%
- Return on Equity TTM:
- 8.57%
Company Profile
Advanced Enzyme Technologies Ltd had its IPO on under the ticker symbol ADVENZYMES.
The company operates in the Basic Materials sector and Specialty Chemicals industry. Advanced Enzyme Technologies Ltd has a staff strength of 338 employees.
Stock update
Shares of Advanced Enzyme Technologies Ltd opened at ₹325.1 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹308.3 - ₹329.5, and closed at ₹311.
This is a -4.2% slip from the previous day's closing price.
A total volume of 42,011 shares were traded at the close of the day’s session.
In the last one week, shares of Advanced Enzyme Technologies Ltd have slipped by -4.15%.
Advanced Enzyme Technologies Ltd's Key Ratios
Advanced Enzyme Technologies Ltd has a market cap of ₹37.16 billion, indicating a price to book ratio of 2.9325 and a price to sales ratio of 6.5073.
In the last 12-months Advanced Enzyme Technologies Ltd’s revenue was ₹5.67 billion with a gross profit of ₹3.61 billion and an EBITDA of ₹1.64 billion. The EBITDA ratio measures Advanced Enzyme Technologies Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Advanced Enzyme Technologies Ltd’s operating margin was 24.48% while its return on assets stood at 5.84% with a return of equity of 8.57%.
In Q1, Advanced Enzyme Technologies Ltd’s quarterly earnings growth was a positive 61.3% while revenue growth was a positive 21.6%.
Advanced Enzyme Technologies Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 35.1269
- PEG
Its diluted EPS in the last 12-months stands at ₹9.46 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Advanced Enzyme Technologies Ltd’s profitability.
Advanced Enzyme Technologies Ltd stock is trading at a EV to sales ratio of 5.7612 and a EV to EBITDA ratio of 17.7336. Its price to sales ratio in the trailing 12-months stood at 6.5073.
Advanced Enzyme Technologies Ltd stock pays annual dividends of ₹0 per share, indicating a yield of 1.83% and a payout ratio of 63.71%.
Balance sheet and cash flow metrics
- Total Assets
- ₹14.22 billion
- Total Liabilities
- ₹775.66 million
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 63.71%
Advanced Enzyme Technologies Ltd ended 2024 with ₹14.22 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹14.22 billion while shareholder equity stood at ₹12.35 billion.
Advanced Enzyme Technologies Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹775.66 million in other current liabilities, in common stock, ₹10.02 billion in retained earnings and ₹3.21 billion in goodwill. Its cash balance stood at ₹964.20 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹77.99 million.
Advanced Enzyme Technologies Ltd’s total current assets stands at ₹7.21 billion while long-term investments were ₹0 and short-term investments were ₹3.89 billion. Its net receivables were ₹1.00 billion compared to accounts payable of ₹242.21 million and inventory worth ₹1.24 billion.
In 2024, Advanced Enzyme Technologies Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Advanced Enzyme Technologies Ltd paid ₹0.64 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹311
- 52-Week High
- ₹346.15
- 52-Week Low
- ₹221.1043
- Analyst Target Price
- ₹
Advanced Enzyme Technologies Ltd stock is currently trading at ₹311 per share. It touched a 52-week high of ₹346.15 and a 52-week low of ₹346.15. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹315.07 and 200-day moving average was ₹281.08 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 6051.4% of the company’s stock are held by insiders while 1723.1% are held by institutions.
Frequently Asked Questions About Advanced Enzyme Technologies Ltd
Similar Industry Stocks (Specialty Chemicals)
Most Active
Top Gainers
Top Losers
About
Advanced Enzyme Technologies Limited researches and develops, manufactures, and markets enzymes and probiotics in India, the United States, Asia, Europe, and internationally. The company offers enzymes for human healthcare and animal nutrition, fruit and vegetable processing, baking, brewing, and malting, and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications. It provides non-food processing enzymes for textile processing, leather, pulp and paper, detergents and cleaning aids, bio-fuels, and biocatalysis. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India.